BioMarin Pharmaceutical Inc. buy Canaccord Genuity Group Inc.
Start price
26.02.26
/
50%
€51.78
Target price
26.02.27
€87.99
Performance (%)
-10.35%
Price
29.04.26
€46.42
Summary
This prediction is currently active. The price of BioMarin Pharmaceutical Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -10.35%. This prediction currently runs until 26.02.27. The prediction end date can be changed by Canaccord_Genuity_Gr at any time. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| BioMarin Pharmaceutical Inc. | 0.324% | 0.324% |
| iShares Core DAX® | -1.499% | 7.705% |
| iShares Nasdaq 100 | 1.380% | 16.275% |
| iShares Nikkei 225® | -1.992% | 13.113% |
| iShares S&P 500 | 0.345% | 10.816% |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical (BMRN) was given a new $104.00 price target by Canaccord Genuity Group Inc.. They now have a "buy" rating on the stock.
Ratings data for BMRN provided by MarketBeat